scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1011889179 |
P356 | DOI | 10.1186/S13063-016-1539-2 |
P8608 | Fatcat ID | release_u6wzyd4xsfci3b3kd4l5unefly |
P932 | PMC publication ID | 4992221 |
P698 | PubMed publication ID | 27542731 |
P50 | author | Véronique Sébille | Q57015586 |
Karim Asehnoune | Q91728919 | ||
Fanny Feuillet | Q114436134 | ||
P2093 | author name string | Mickael Vourc'h | |
BACLOREA trial group | |||
Pierre-Joachim Mahe | |||
P2860 | cites work | Brain shrinkage in alcoholics: a decade on and what have we learned? | Q33658092 |
Alcohol screening scores and 90-day outcomes in patients with acute lung injury | Q33723496 | ||
Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam | Q33993651 | ||
Alcohol-attributable mortality in France | Q34035895 | ||
Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit | Q34313233 | ||
Sleep disturbances in the wake of traumatic events | Q34467534 | ||
Alcohol as a risk factor for brain damage: neurologic aspects | Q34478345 | ||
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study | Q34722965 | ||
Sample size recalculation in internal pilot study designs: a review | Q36593600 | ||
Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population | Q37238321 | ||
Anticipating and managing postoperative delirium and cognitive decline in adults | Q37903162 | ||
A prospective study of delirium in hospitalized elderly | Q40764917 | ||
Delirium tremens: a review | Q40782116 | ||
Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers. | Q42640821 | ||
At-risk drinking is independently associated with ICU and one-year mortality in critically ill nontrauma patients*. | Q43441882 | ||
Postoperative morbidity among symptom-free alcohol misusers | Q43956696 | ||
The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods. | Q44824453 | ||
Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients | Q46880812 | ||
Chronic alcoholism increases the induction dose of propofol | Q48213371 | ||
Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial. | Q51001303 | ||
Influence of alcohol on anesthetic requirements and acute toxicity. | Q51873026 | ||
Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients | Q52045518 | ||
Alcohol as a Risk Factor for Brain Damage: Neurologic Aspects | Q56227761 | ||
Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial | Q63464422 | ||
Epidemiologic study of anesthesia complications in France | Q70337766 | ||
Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract | Q71604425 | ||
The new practice guidelines for pain, agitation, and delirium | Q86255429 | ||
P433 | issue | 1 | |
P921 | main subject | study protocol | Q111908491 |
P304 | page(s) | 415 | |
P577 | publication date | 2016-08-19 | |
P1433 | published in | Trials | Q7840023 |
P1476 | title | Baclofen to prevent agitation in alcohol-addicted patients in the ICU: study protocol for a randomised controlled trial | |
P478 | volume | 17 |
Search more.